BANK OF MONTREAL /CAN/ - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$428,000
+380.9%
27,827
+952.5%
0.00%
Q1 2021$89,000
-62.0%
2,644
-68.4%
0.00%
Q4 2020$234,000
+138.8%
8,355
+233.8%
0.00%
Q3 2020$98,000
-42.7%
2,503
-35.5%
0.00%
Q2 2020$171,000
+34.6%
3,880
-20.5%
0.00%
Q4 2019$127,000
+36.6%
4,880
+43.4%
0.00%
Q3 2019$93,000
+6.9%
3,402
+5.6%
0.00%
Q2 2019$87,0003,2230.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders